# Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

> **NCT05266807** · PHASE3 · RECRUITING · sponsor: **Benoit Guery** · enrollment: 220 (estimated)

## Conditions studied

- Clostridioides Difficile Infection

## Interventions

- **DRUG:** oral capsulized Fecal Microbiota Transplantation
- **DRUG:** Vancomycin or Fidaxomicin

## Key facts

- **NCT ID:** NCT05266807
- **Lead sponsor:** Benoit Guery
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-15
- **Primary completion:** 2027-04-01
- **Final completion:** 2028-01-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266807, "Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05266807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*